These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17703566)

  • 21. Delivery of agricultural technology to resource-poor farmers in Africa.
    Mignouna HD; Abang MM; Omanya G; Nang'ayo F; Bokanga M; Boadi R; Muchiri N; Terry E
    Ann N Y Acad Sci; 2008; 1136():369-76. PubMed ID: 17954683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Building bioinformatics capacity in West Africa.
    Nashiru O; Huynh C; Doumbia S; Kissinger JC; Isokpehi RD; Olorunsogo OO
    Afr J Med Med Sci; 2007; 36 Suppl():15-8. PubMed ID: 17703558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulating developments in embryonic stem cell research in Africa: a third person's perspective.
    Amechi EP
    J Law Med; 2008 Feb; 15(4):571-86. PubMed ID: 18365523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intellectual property and patent in stem cell research era.
    Kiatpongsan S
    J Med Assoc Thai; 2006 Nov; 89(11):1984-6. PubMed ID: 17205886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biotech firms join charities in drive to help Africa's farms.
    Hoag H
    Nature; 2003 Mar; 422(6929):246. PubMed ID: 12646881
    [No Abstract]   [Full Text] [Related]  

  • 26. Current status of regulating biotechnology-derived animals in Canada: animal health and food safety considerations.
    Kochhar HP; Evans BR
    Theriogenology; 2007 Jan; 67(1):188-97. PubMed ID: 17097725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From research to control: Translating research findings into health policies, operational guidelines and health products.
    Kilama W
    Acta Trop; 2009 Nov; 112 Suppl 1():S91-S101. PubMed ID: 19686696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayh-Dole: if we knew then what we know now.
    Boettiger S; Bennett AB
    Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
    [No Abstract]   [Full Text] [Related]  

  • 29. Intellectual property conundrum for the biological sciences.
    Olds JL
    Anat Rec B New Anat; 2004 Mar; 277(1):5-9. PubMed ID: 15052648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA-based patents: an empirical analysis.
    Mills AE; Tereskerz P
    Nat Biotechnol; 2008 Sep; 26(9):993-5. PubMed ID: 18779808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three legal frameworks for regulating genetic technology.
    Huhn W
    J Contemp Health Law Policy; 2002; 19(1):1-36. PubMed ID: 12733222
    [No Abstract]   [Full Text] [Related]  

  • 32. Socioeconomic and pedagogical issues in biotechnology in Africa: a sociologist's viewpoint.
    Erinosho L
    Afr J Med Med Sci; 2007; 36 Suppl():77-9. PubMed ID: 17703569
    [No Abstract]   [Full Text] [Related]  

  • 33. Naturally occurring asbestos: a recurring public policy challenge.
    Lee RJ; Strohmeier BR; Bunker KL; Van Orden DR
    J Hazard Mater; 2008 May; 153(1-2):1-21. PubMed ID: 18180100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. South Africa--blazing a trail for African biotechnology.
    Motari M; Quach U; Thorsteinsdóttir H; Martin DK; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC37-41. PubMed ID: 15583683
    [No Abstract]   [Full Text] [Related]  

  • 35. Challenges of anticancer chemotherapy in Africa.
    Ndom P
    Can J Urol; 2008 Feb; 15(1):3909-11. PubMed ID: 18304402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A regulatory governance perspective on Health Technology Assessment (HTA) in Sweden.
    Shah SM; Barron A; Klinger C; Wright JS
    Health Policy; 2014 May; 116(1):27-36. PubMed ID: 24655685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodiversity, biopiracy and benefits: what allegations of biopiracy tell us about intellectual property.
    Hamilton C
    Dev World Bioeth; 2006 Dec; 6(3):158-73. PubMed ID: 17038007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Russia becomes attractive as a source of IP for biotechs.
    Katsnelson A
    Nat Biotechnol; 2004 Sep; 22(9):1060. PubMed ID: 15340454
    [No Abstract]   [Full Text] [Related]  

  • 39. Sustainable transfer of biotechnology to developing countries: fighting poverty by bringing scientific tools to developing-country partners.
    Coloma J; Harris E
    Ann N Y Acad Sci; 2008; 1136():358-68. PubMed ID: 17954678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health technology assessment (HTA): definition, role and use in the changing healthcare environment.
    Gallio D; Berto P
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():7-11. PubMed ID: 18924460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.